Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

NCT05582707 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Loss of Financial Sponsor

Conditions

Intracerebral Haemorrhage, Intraventricular

Interventions

DRUG: Pioglitazone 15mg

Sponsor

University of Maryland, Baltimore

Collaborators

Nico Corporation